Cancer remains the dominant disease target for biotech through to 2010

Journal of Commercial Biotechnology

Volumn 12, Issue 4, 2006, Pages 294-298

  Pijpers, Fleur ^a   Belsey, Mark J ^b  

^a Datamonitor ^*  (United States)

^b Healthcare Competitive Intelligence Team   (United Kingdom)

Author keywords

Biological; Market analysis; Monoclonal antibody; Oncology; Recombinaant proteins; Supportive care product

Indexed keywords

MARKET ANALYSIS; MONOCLONAL ANTIBODY; SUPPORTIVE CARE PRODUCT;

ANTIBODIES; BIOMEDICAL EQUIPMENT; BIOTECHNOLOGY; GENETIC ENGINEERING;

ONCOLOGY;

BEVACIZUMAB; BIOLOGICAL PRODUCT; ERLOTINIB; GEMCITABINE; HUMAN GROWTH HORMONE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN; RITUXIMAB; TRASTUZUMAB;

ARTICLE; BIOTECHNOLOGY; BREAST CANCER; CANCER; COLORECTAL CANCER; DRUG APPROVAL; DRUG INDUSTRY; DRUG MARKETING; LUNG CANCER; PROSTATE CANCER;

EID: 34447278609     PISSN: 14628732     EISSN: None     Source Type: Journal    
DOI: 10.1057/palgrave.jcb.3040179     Document Type: Article

References (5)

1. Belsey, M. and Pavlou, A. (2005), 'Leading therapeutic rDNA sales forecast and analysis to 2010', J. Comm. biotechnol., Vol. 12, pp. 69-73.
2. Belsey, M.J., Harris, L.M., Das, R.R. and Chertknow, J. (2006) 'Biosimilars: Initial excitement gives way to reality', Nat. Rev. Drug Discov., Vol. 5, pp. 535-536.
3. World Health Organization:URL: http://www.who.int/cancer/en/
4. Cancer Facts & Figures 2006:URL: http://www.cancer.org/downloads/STT/ CAFF2006PWSecured.pdf
5. Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J., Gallinger, S., Au, H., Ding, K., Christy-Bittel, J. and Parulekar, W. (2005) 'Erlotinib plus gemcitabine compared to gemcitabine alone in patients wants advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical trials Group', Proc. Am. Soc. Clin. Oncol., Abstract 1, http://www.asco.org/portal/site/ASCO/ menuitem.34d60f5624ba07fd506fe310ee37a01d/?vgnextoid= 76f8201eb61a7010VgnVCM100000ed730ad1RCRD&vmview= abst_detail_view&conflD=34&abstractID=33471.